Exchange: OTC·Updated 02:26 PM EDT
HEPA logo

HEPA Hepion Pharmaceuticals Inc

$0.088
$0.022
(33.33%)
Today
Mkt Cap$5.95M
Vol24,813.00

About HEPA

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
48

Neutral Sentiment

How do you feel about HEPA?

Advertisement|Remove ads.